About Clinical Hospital «NEUROVITA»
AO NeuroVita Clinical Hospital (further referred to as the Hospital) is a medical center that provides a full range of highly technological specialized medical-biological services. We offer non-invasive and minimally invasive highly technological procedures for diagnostics and therapy of the frequent non-infectious disorders, such as oncological, cardio-vascular, neural, hereditary and autoimmune diseases in the premises of international level. Our Hospital is a national leader in predictive and personalized (individually tailored) medicine and has acquired a broad experience of effective clinical patient-oriented practice for over twenty years.
Our mission is to extend the average lifespan and active longevity of an individual by means of extra early molecular-biological diagnostics of lethal oncological, autoimmune neurodegenerative and other diseases at the preclinical stage, to predict the risk of onset of the disease and to prevent its progress and should this be the case to offer preventive and individually tailored therapy.
One of our advantages as compared to other medical centers is our readiness to help difficult patients in severe conditions and to offer them the authorial biomedical technologies that integrate the diagnostic-therapeutic services approved in Russia and in the countries of the Eurasian Economic Union (EEU). Most of our approaches are unique and protected by the patents (30 patents of the Russian Federation and 1 US patent for invention).
Our experts primarily evaluate the opportunity to use low invasive interventions avoiding massive surgery and restoring the damaged structure to recover the disordered function of the injured organ and tissue. In the most complex cases our experts consult the leading specialists of the federal research medical centers of the Ministry of Healthcare of Russia and the Russian Academy of Science in Moscow, Saint-Petersburg, and Novosibirsk.
The internal ecosystem of our Hospital is targeted at various medical and paramedical services to meet all scope of the patient’s needs during their stay in the Hospital. Our specialists are open for active participation in the patients and their relatives fighting with the disease.
When the conventional methods of diagnostics and treatment defined by the Standards of Medical Care are exhausted and/or their further application is limited, the patient has to search for professional alternatives to provide his/her further survival. The patients with grave oncological, autoimmune, neurodegenerative and hereditary diseases badly need the rehabilitative-restorative treatment of the complications of high-dose chemotherapy, chronic radiation disease and radiation-induced necrosis of organs and tissues. In some cases, the Standards of Medical Care are unable to recommend anything but palliative assistance and a hospice. We are convinced that in both cases the patients can be offered the opportunities of personalised and post-genome medicine.
Being able to restore the function, the personalised methods of therapy can be an efficient option for reconstructive and esthetic treatment, pain killing, drug abuse prevention and general improvement of life quality.
Personalized personalised and post-genome medicine opens new horizons for diagnostics and therapy and is able to restore or to replace tissues and organs damaged by age, disease or injury. The promising evidence of the pre-clinical and clinical research confirm the opportunity of successful treatment both of chronic conditions, and of acute pathologies independent on how severe and pronounced the process is. As far as tissue engineering, bioengineering and personalised medicine as the branch of healthcare have emerged about two decades ago, some of the methods have already been approved in Russia and in the world, and the appropriate medical services have been approved as well. Hence, currently, they can be offered to the patients although they are not included in the treatment standards and the regulations of the diagnostics and treatment of the Compulsory Health Insurance and voluntary health insurance.
